Study of Subcutaneous (SC) Belimumab in Pediatric Participants With Systemic Lupus Erythematosus (SLE)
Clinical trial NCT04179032 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04179032
- Sponsor
- GlaxoSmithKline
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-28
- Primary completion
- 2023-01-16
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.